Clinical Trials Browser

Phase 2 × Small Cell Lung Carcinoma × antineoplaston A10 × Clear all

NCT00003496 2017-09-28

Antineoplaston Therapy in Treating Patients With Recurrent or Extensive-Stage Small Cell Lung Cancer

Phase 2 Terminated

Small Cell Lung Carcinoma